Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case Report

ABSTRACT Tolvaptan is widely used as an adjunct oral diuretic to loop and thiazide diuretics for the management of fluid overload in patients with congestive heart failure. Recently, tolvaptan sodium phosphate (TSP), a water‐soluble prodrug of tolvaptan, was developed for intravenous administration...

Descripció completa

Dades bibliogràfiques

Autors principals:	Takaya Uno, Ichiro Nakakura, Akari Ikeda, Atsuki Hosoda, Yutaro Mukai, Kaori Yamanishi, Naohiro Ohara, Kaori Imanishi, Yoshiko Une, Satoshi Yokoyama, Kouichi Hosomi
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-06-01
Col·lecció:	Pharmacology Research & Perspectives
Matèries:	chronic kidney disease heart failure tolvaptan tolvaptan sodium phosphate
Accés en línia:	https://doi.org/10.1002/prp2.70252
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!